Company / CapEx per Share
NewAmsterdam Pharma Co N.V. CapEx per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
-63.4%
vs FY2024
Sector context
#134 of 192
Health Care
What the data says
At $0.01, NewAmsterdam Pharma Co N.V.'s capex per share ranks #134 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 5 years, ranging from $0.00 in FY2023 to $0.02 in FY2024.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of -16.5%.
Improved from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -16.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#134 of 192 in Health CareTop 70% of 192This company $0.01 Sector average $3.54
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 63.4% year-over-year.
- Ranks #134 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -63.4% |
| FY2024 | $0.02 | +2700.0% |
| FY2023 | $0.00 | -94.3% |
| FY2022 | $0.01 | +433.0% |
| FY2021 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026